Tectonic Therapeutic | AVRO - Current Liabilities


Tectonic Therapeutic reported $12.96M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Akebia Therapeutics USD 173.88M 10.95M Mar/2026
Alnylam Pharmaceuticals USD 1.35B 116.87M Mar/2026
Celltrion KRW 292.71B 9.09B Mar/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 38.28M 7.55M Mar/2026
Divis Laboratories Ltd INR 20.43B 3.15B Mar/2026
Gilead Sciences USD 9.48B 2.34B Mar/2026
Ionis Pharmaceuticals USD 717M 66M Mar/2026
Kangmei Pharma CNY 5.38B 433.79M Mar/2026
Karyopharm Therapeutics USD 92.06M 4.9M Dec/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
MacroGenics USD 95.94M 52.82M Mar/2026
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Organigram Holdings CAD 88.74M 5.31M Mar/2026
Ovoca Bio EUR 186K 2.26M Jun/2025
Pfizer USD 34.35B 2.64B Mar/2026
Pharma Mar EUR 89.23M 4.65M Mar/2026
Qiagen NV USD 512.14M 461.26M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sanofi EUR 30.01B 1.66B Mar/2026
Sarepta Therapeutics USD 499.16M 596.13M Mar/2026
Sartorius EUR 2.11B 145.8M Mar/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Takeda JPY 2.43T 180.65B Mar/2026
Tilray USD 259.32M 8.32M Sep/2025
Zealand Pharma A/S 664.96M 513.61M Dec/2025
Zz Pientze Pharmaceu CNY 2.28B 134.52M Mar/2026